C

Cardiology Associates Research Company | Daytona Beach, FL

Research site

(Unclaimed)

Location

305 Memorial Medial Parkway, Suite 501, Daytona Beach, Florida, United States of America

Site insights

Top conditions

Top treatments

Bococizumab

Apixaban

BAY 2433334

Finerenone

PB1046

Vericiguat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling

Atrial Fibrillation

Drug: Apixaban Placebo

Drug: Milvexian

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function (PROTECT IV)

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided hea...

Enrolling

Coronary Artery Disease

Left Ventricular Dysfunction

Device: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®

Device: IABP Intra-aortic balloon pump